Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Levetiracetam NDC 63629-4675 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The given text provides a formula to calculate the total daily dose of a medication based on the patient's weight and the recommended dose in mg/kg/day. The medication concentration is given as 100 mg/mL.*
This text describes a formula used to estimate the renal function of female patients. The formula uses the patient's age, weight, and serum creatinine levels to calculate CLer, which is then adjusted to account for the patient's body surface area.*
This appears to be a chart or graph showing percentages related to two groups of individuals taking different amounts of Levetiracetam medication. Without more context or information, it is difficult to provide a more specific description.*
This appears to be a chart or table displaying the percentages of patients in a study who received a placebo or different doses of a medication called Levetiracetam. The percentages range from 0% to 35.2%. However, without additional information, it is unclear what the study was investigating and what the percentages represent.*
This table displays the percentages of patients in a study who were either in the Placebo group or the Levetiracetam group. The first column shows the percentage of patients in the Placebo group and the second column shows the percentage of patients in the Levetiracetam group. The output does not provide any further information to determine the specifics of the study.*
This is a chart showing the percentage of patients in a study who fall under certain categories. The categories are shown on the left-hand side, and the percentages are on the right. The study compares a placebo group (with 84 participants) to a levetiracetam group (with 79 participants). The chart appears to show that neither group had 100% success in the outcome being measured. It is not clear what the outcome being measured is from the given text.*
This appears to be a label from a package of tablets named "Keppra 250mg," which is manufactured by Lupin Limited. The package contains 60 tablets and the expiration date is unspecified aside from showing "EXP MM/YY." The package was prepackaged by someone named Bryant Ranck. The label also includes a phone number and address for Bunbank, CA, as well as instructions to keep the medication away from children and store at a temperature of 20-25°C (68-77°F). The last line seems to include a barcode number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.